 |
Breast Cancer Update - A CME Audio Series and Activity |
|
STATEMENT OF NEED/TARGET AUDIENCE
Breast cancer is one of the most rapidly evolving fields in medical oncology. Published results from a plethora of
ongoing clinical trials lead to the continuous emergence of new therapeutic agents and changes in the indications
for existing treatments. In order to offer optimal patient care — including the option of clinical trial participation
— the practicing medical oncologist must be well informed of these advances. To bridge the gap between research
and patient care, this special edition of Breast Cancer Update utilizes case-based discussions held between
community oncologists and research leaders at two live CME meetings to demonstrate the integration of clinical
research data into clinical practice.
GLOBAL LEARNING OBJECTIVES
- Critically evaluate the clinical implications of emerging clinical trial data, patterns of care data and patients’
perspectives on breast cancer treatment decisions.
- Counsel women with low-risk invasive disease about the absolute risks and benefits of adjuvant systemic
chemotherapy, and describe the potential utility of a predictive assay to help guide these discussions.
- Counsel postmenopausal patients with ER-positive breast cancer about the risks and benefits of adjuvant
aromatase inhibitors and about switching or sequencing aromatase inhibitors after tamoxifen.
- Counsel premenopausal women about the risks and benefits of adjuvant ovarian ablation in combination
with tamoxifen or aromatase inhibition.
- Distinguish the risk-to-benefit profiles of chemotherapeutic agents and combinations to determine a
management algorithm for metastatic breast cancer.
- Develop and explain a management strategy for therapy for patients with ER-positive, metastatic disease
including sequencing of hormonal therapies.
- Describe and implement an algorithm for treatment of HER2-positive breast cancer.
PURPOSE OF THIS ISSUE OF BREAST CANCER UPDATE
The purpose of this special edition of Breast Cancer Update is to support these global objectives by offering
the perspectives of the faculty on the integration of emerging clinical research data into the management of
breast cancer.
ACCREDITATION STATEMENT
Research To Practice is accredited by the Accreditation Council for Continuing Medical Education to provide
continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
Research To Practice designates this educational activity for a maximum of 3.25 category 1 credits toward the
AMA Physician’s Recognition Award. Each physician should claim only those credits that he/she actually spent in
the activity.
HOW TO USE THIS MONOGRAPH
This CME activity contains both audio and print components. To receive credit, the participant should listen to
the CDs or tapes, review the monograph and complete the post-test and evaluation form located in the back of
this monograph or on our website. This monograph contains edited comments, clinical trial schemas, graphics
and references that supplement the audio program. www.BreastCancerUpdate.com includes an easy-to-use,
interactive version of this monograph with links to relevant full-text articles, abstracts, trial information and other
web resources indicated here in blue underlined text.
|
